SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001629137-16-000048
Filing Date
2016-05-12
Accepted
2016-05-12 16:53:50
Documents
50
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gbt10q2016q1.htm 10-Q 812120
2 EXHIBIT 31.1 exhibit311q12016.htm EX-31.1 14247
3 EXHIBIT 31.2 exhibit312q12016.htm EX-31.2 14135
4 EXHIBIT 32.1 exhibit321q12016.htm EX-32.1 8911
  Complete submission text file 0001629137-16-000048.txt   3409213

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gbt-20160331.xml EX-101.INS 563835
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gbt-20160331.xsd EX-101.SCH 27626
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gbt-20160331_cal.xml EX-101.CAL 43809
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gbt-20160331_def.xml EX-101.DEF 113214
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gbt-20160331_lab.xml EX-101.LAB 387412
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gbt-20160331_pre.xml EX-101.PRE 219604
Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 161644683
SIC: 2834 Pharmaceutical Preparations